Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...

mRNA vaccines leverage a piece of genetic code known as messenger RNA (mRNA). This genetic code instructs cells in the body ...

The team’s RNA-LNP approach – described in the journal Cell – works by reprogramming the TME using a sample of the tumour itself, so it can work both as a vaccine to stimulate an immune ...

COVID-19 vaccine DNA contamination claims aren't new, but have resurfaced in the wake of a Canadian study that some ...

It’s a sharp turn in fortune for the chief executive and company veteran who oversaw development and mass production of the novel RNA vaccine, a race against the coronavirus that helped get the ...

Some of the newly created vaccines, including the one now approved in the UK developed by Pfizer/BioNTech, use a fragment of the virus's genetic material - or messenger RNA. "Injecting RNA into a ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work ...

Many leading pharma and biotechs have invested in messenger RNA (mRNA) technology to develop COVID-19 vaccines and are now exploring their potential in other disease areas (Figure 1). The success ...

[85] Even higher stability and extended shelf life can be expected of RNA vaccines prepared under good manufacturing process conditions. Increasing prevalence of allergy and the resulting ...

The UK is making progress in developing cancer vaccines, but there are still challenges ahead, Chris Baraniuk reports The UK is on its way to becoming a hotbed of cancer vaccine trials. In May this ...